LIVELY HEARING CORPORATION – Trademark Portfolio
Entity Type: 03
LIVELY HEARING CORPORATION holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 7 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include LIFE IS RICHER WHEN YOU CAN HEAR IT. The owner is based in NEW YORK, NY.
85 5TH AVENUE
8TH FLOOR
NEW YORK, NY 10003
Showing of trademarks Trademarks
Trademark Classifications
LIVELY HEARING CORPORATION's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does LIVELY HEARING CORPORATION have?
LIVELY HEARING CORPORATION has 7 U.S. trademarks filed with the USPTO. Of these, 1 registered, 6 abandoned.
What trademark classes does LIVELY HEARING CORPORATION file in?
LIVELY HEARING CORPORATION files trademarks across 3 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 44 (Medical Services). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are LIVELY HEARING CORPORATION's most well-known trademarks?
LIVELY HEARING CORPORATION's registered trademark portfolio includes well-known marks such as LIFE IS RICHER WHEN YOU CAN HEAR IT. These are among 1 currently registered trademark in the portfolio.
What is LIVELY HEARING CORPORATION's trademark registration success rate?
LIVELY HEARING CORPORATION has a 14% trademark registration rate, with 1 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.